CNBX Gross Margin

The Gross Margin of CNBX Pharmaceuticals Inc (CNBX) is 100.00%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

CNBX Gross Margin - Historical Value

Date	Value
2024-08-31	100.00%

CNBX Gross Margin - Peers Comparison

Ticker	Name	Value
GBLX	GB Sciences Inc	6.09%
NBRV	Nabriva Therapeutics PLC	22.62%
ADIL	Adial Pharmaceuticals Inc	7775.20%
ARTL	Artelo Biosciences Inc	7775.20%
TMBR	Timber Pharmaceuticals Inc	-50.00%
NGEN.V	NervGen Pharma Corp	7775.20%
NLSP	NLS Pharmaceutics AG	7775.20%
BVXV	BiondVax Pharmaceuticals Ltd	7775.20%
HOTH	Hoth Therapeutics Inc	7775.20%
RVPH	Reviva Pharmaceuticals Holdings, Inc.	7775.20%
TRVI	Trevi Therapeutics Inc	7775.20%
ACER	Acer Therapeutics Inc	100.00%
BETR.CN	BetterLife Pharma Inc	7775.20%
BUDZ	Weed Inc	7775.20%
NBY	NovaBay Pharmaceuticals Inc	66.26%
NPTX	Neuropathix Inc	100.00%
PHBI	Pharmagreen Biotech Inc	51.03%
PRTT	Protect Pharmaceutical Corporation Inc	7775.20%
PULM	Pulmatrix Inc	7775.20%
AVCN.TO	Avicanna Inc	45.38%
AXIM	Axim Biotechnologies Inc	95.00%
CNSP	CNS Pharmaceuticals Inc	7775.20%
TCCR	Triccar Inc	37.67%